Search clinical trials for: 0.5-mg Ranibizumab

Total 15534 results

Florida International University
National Institute of Mental Health (NIMH)

Completed

Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

United States
Oslo Metropolitan University
University of Oslo; Nofima; Mills DA

Completed

Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects

Gut Microbiota | Satiety | Post Prandial Blood Glucose

Norway
Celgene

Completed

Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Manhattan Medical Research Practice, PLLC
Endo Pharmaceuticals

Unknown

Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response

Peyronie's Disease

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

Atherosclerosis

United Kingdom
Nymox Corporation

Completed

Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

Prostate Cancer

United States
LG Life Sciences

Completed

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, China
University of Iowa

Completed

Essential Fatty Acids for Major Depression

Major Depression

United States
Arcutis Biotherapeutics, Inc.

Completed

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Psoriasis

Canada, United States
DR. MALA KHAN
Dhaka Medical College

Completed

Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo (VEP-COV)

COVID19

Bangladesh
GlaxoSmithKline

Completed

Efficacy of Three Toothpastes Using an in Situ Caries Model

Dental Caries

United States
GlaxoSmithKline

Completed

Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)

Dermatitis

United Kingdom
Yung Shin Pharm. Ind. Co., Ltd.

Terminated

Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer (VMS)

Breast Cancer | Hot Flashes

Taiwan
Pfizer

Terminated

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD (PERSPECTIVES)

Macular Degeneration | Age Related Macular Degeneration (AMD) | Choroidal Neovascularization (CNV)

Canada, Belgium, United Kingdom, France, Poland, Spain, Turkey, Czech Republic, Italy, Greece, Germany, Austria, Portugal, Denmark, Finland
Galderma R&D

Completed

Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.

Healthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected Skin

France
Santen Inc.

Completed

A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration (PAVE)

Age-Related Macular Degeneration

United States
GlaxoSmithKline

Completed

Bioequivalence Trial of Alprazolam 0.5 mg Tablets

Anxiety Disorders
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine

Influenza | Flu

China
Trevena Inc.

Completed

Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects

Pain, Acute

United States
Kowa Company, Ltd.

Completed

A Phase III Long Term Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Bio Genuine (Shanghai) Biotech Co., Ltd.

Recruiting

Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis

Endometriosis | Moderate to Severe Endometriosis-associated Pain

China
Kyowa Kirin Co., Ltd.

Completed

A Study of OPC-262 in Patients With Type 2 Diabetes

Diabetes Type 2

Japan
National and Kapodistrian University of Athens
Harokopio University

Recruiting

High Protein Effect on Body Composition and Sarcopenia Markers in Older Patients With Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus

Greece
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR); ICES

Active, not recruiting

Outcomes of a Higher vs. Lower Hemodialysate Magnesium Concentration (Dial-Mag Canada)

Kidney Diseases | Hemodialysis | End-Stage Kidney Disease

Canada
University of California, Davis
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis

Diabetic Ketoacidosis | Cerebral Edema

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery (TEXT-TKR)

VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery

Belgium, Italy, Malaysia, Latvia, Spain, Turkey, Bulgaria, United States, Lithuania, Russian Federation, Ukraine, Japan, Argentina, Brazil, Canada, Poland
Al-Rasheed University College

Completed

Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS

Polycystic Ovary Syndrome

Iraq
Bayer
Merck Sharp & Dohme LLC; Duke Clinical Research Institute; Canadian VIGOUR Centre

Completed

Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF (VITALITY-HFpEF)

Chronic Heart Failure With Preserved Ejection Fraction

Spain, United States, Belgium, Singapore, Taiwan, Canada, Japan, Italy, Austria, Bulgaria, Germany, Greece, Israel, Poland, Portugal, Hungary, Russian Federation, Argentina, Colombia, Malaysia, South Africa
Minerva Neurosciences

Completed

A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Finland, Georgia, Moldova, Republic of, Poland, Ukraine
University of Oxford
NIHR Oxford Health Biomedical Research Centre

Not yet recruiting

Semaglutide and Cognition in Healthy Volunteers (OxSENSE)

Cognitive Change

United Kingdom
G. d'Annunzio University

Completed

Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema (LED)

Diabetic Macular Edema
Children's Hospital Los Angeles

Not yet recruiting

Maralixibat in Patients With Cystic Fibrosis and Constipation, A Within-Subjects Pilot Study

Cystic Fibrosis | Constipation Chronic Idiopathic

United States
GlaxoSmithKline

Completed

Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers

Alopecia

Australia
PharmaMar
Apices Soluciones S.L.

Completed

Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 (APLICOV-PC)

COVID-19

Spain
Lpath, Inc.

Completed

A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers

Healthy Subjects

United States
Futura Medical Developments Ltd.

Completed

Evaluating MED2005 & Nitrostat Bioavailability (FM58)

Erectile Dysfunction

United Kingdom
University of Pennsylvania

Completed

Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA

Osteoarthritis | Total Knee Arthroplasty | Post Operative Pain Control

United States
MedImmune LLC

Completed

Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas

Relapsed/Refractory Aggressive B-cell Lymphomas

United States
Eisai Co., Ltd.

Completed

A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Alzheimer's Disease

Japan
Formosa Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery

Ocular Inflammation and Pain After Cataract Surgery

United States
Chong Kun Dang Pharmaceutical

Completed

Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

Diabetes Mellitus, Type II

Korea, Republic of
Medibiofarma S.L.

Completed

Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers

Safety and Pharmacokinetic

Spain
Alcon Research

Completed

WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination

Age Related Macular Degeneration
RemeGen Co., Ltd.

Recruiting

A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Shire

Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

Short Bowel Syndrome

United States, France, Germany, Canada, Netherlands, Poland, Denmark, Belgium, United Kingdom
George Medicines PTY Limited

Completed

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension (GMRx2_ACT)

Hypertension

Australia, United States, United Kingdom, Poland, Sri Lanka, New Zealand, Czechia
Tunitas Therapeutics, Inc.
Tunitas Therapeutics Australia Pty Ltd

Terminated

Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects

Allergy and Immunology

Australia
PurGenesis Technologies Inc.

Completed

Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

Canada
Dermavant Sciences GmbH

Completed

A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Relapsing Remitting Multiple Sclerosis

Search clinical trials for: 0.5-mg Ranibizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations